Medicenna Therapeutics Corp experienced a notable uptick in its stock price, reflecting positive investor sentiment.
In yesterday’s trading session, Medicenna Therapeutics Corp (MDNA.TO) saw its stock price rise by 6.49%, closing at CA$0.41. This increase comes amid a backdrop of ongoing developments in the biotech sector, which may have contributed to investor optimism.
Advertisement
Medicenna Therapeutics Corp
MDNA.TO
MDNA.TO
Medicenna Therapeutics Corp
WealthAwesomeMarket cap
$37.84M
52W high
$1.97
52W low
$0.34
1W change
+3.80%
Beta
2.10
Analyst Price Targets
Based on analyst covering MDNA · as of Sep 17, 2026
Wall Street analysts forecast MDNA stock price to rise 680.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.20
+680.5% Upside
Current Price
C$0.41
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDNA's historical volatility
30-Day Vol
50.8%
Annualized
90-Day Vol
51.4%
Annualized
Trend (90d)
+37.5%
Annualized drift
90d Mean
C$0.47
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.43 | C$0.36 – C$0.51 |
| 60 trading days | C$0.45 | C$0.35 – C$0.57 |
| 90 trading days | C$0.47 | C$0.35 – C$0.64 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should keep an eye on Medicenna's future announcements, especially regarding its presentations at upcoming conferences, as these could influence stock performance.
6.49% Surge in Stock Price
Medicenna's stock price increased significantly, reflecting positive market sentiment and potential investor interest in the company's future developments.
Bull case
The recent rise in stock price suggests that investors are becoming more confident in Medicenna's pipeline and its potential to deliver innovative therapies. The company’s involvement in major investment conferences could draw more attention and investment.
Bear case
Despite yesterday's gains, Medicenna is still a small-cap stock, which comes with its own risks. Without significant news or financial updates, the stock could experience volatility, and investors should be cautious about possible price corrections.
Advertisement
Market Performance Overview
Medicenna's stock performance yesterday marked a significant gain, closing at CA$0.41. This uptick may reflect positive investor sentiment, particularly in light of the company's recent announcements and participation in upcoming investment conferences.
Future Outlook
Looking ahead, investors should monitor Medicenna's announcements, especially related to its presentations at major conferences. Such events could provide insights into the company's pipeline and future growth prospects, potentially influencing stock performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
